Buy InflaRx Stock | IFRX Stock Price & Latest News | Public.com
IFRX

InflaRx

$0.00 (0.00%)Today
    Small Market Cap
    View InflaRx (IFRX) stock trends here

    About IFRX

    InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a. Its products include IFX-1 and IFX-2. The company was founded by Niels Christoph Riedemann, Renfeng G...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.15
    -0.3
    -0.45
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.25

    Actual EPS
    Q1 2021

    Stats

    Market Cap$103,89M
    Volume263,82k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$9.70
    1 Year Low$2.52
    Open$3.90
    High$4.01
    Low$3.55

    Buy any stock with any amount of money.

    Download the App
    Download the app